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SUMMARY
Bovine plasma treated with cellulose sulfate produces multiple forms of plasminogen activators. The most fibrinolytic active fraction 
was isolated by preparative electrophoresis. Amidolytic and radial immunodiffusion tests with specific antibodies revealed that the 
most active plasminogen activator possesses properties similar to those of urokinase.
UNITERMS: Bovine; Plasma; Sulfates; Plasminogen activator; Monoclonal antibodies.
INTRODUCTION
The plasminogen activators are proteases which catalyze the conversion of plasminogen to plasmin. Attempts to isolate and characterize plasminogen activators have long 
been reported (Astrup2, 1996; Matsuo el al.n , 1981; Wijingaards 
etal.25, 1982). There are three families of plasminogen activators, 
the single-chain urokinase type plasminogen activators (Scu-PA) 
(Wilson et al.26, 1980; Wunt et a ir1, 1982; Stump et al.22, 1986), 
the double-chain urokinase type plasminogen activators (TC-UK 
and U-PA) (Lijnen et a l.'2, 1987) and the tissue plasminogen 
activators (t-PA) (Bernick; Kwaan3, 1969: Rijken et al.'9, 1979: 
Bernick et a l.4, 1981; Rijken; C ollen20, 1981; M cM ullen; 
Fujikawa15, 1985). Scientific literature points out that bovine plas­
ma treated with sulfate polysaccharide produces a fibrinolytically 
active precipitate (Rothschild et al.2', 1975; Miles et al.'b, 1981; 
Takada et al.23, 1994) containing a mixture of proteins with 
different molecular weights. In the present study, bovine plasma 
was treated with cellulose sulfate; the resulting precipitate had 
various active fibrinolytic forms and the fraction with the highest 
molecular weight was also the most active one in the zymographic 
tests. The objectives of the study were to isolate the most 
fibrinolytic active fraction and to determine its immunological 
nature, using specific antibodies and am idolytic tests with 
chromogenic substrates.
M ATERIAL AND M ETHODS
Activation of the bovine plasma fibrinolytic system
Bovine plasma was diluted 1:10 with distilled water at 2UC 
and treated with cellulose sulfate (Astrup et al.', 1944) to a 25 
j.ig'ml final concentration. After 24 hours the resulting precipitate 
was separated by centrifugation at 13.200 x g and washed with 
small quantities of 0.1 M glycine buffer, pH 9.6, containing 5%
ABBREVIATIONS; CPA: crude plasm inogen activator
PA: plasm inogen activator
TPA: tissue plasm inogen activator
UK: urokinase
NaCl until dissolution. This solution was exhaustively dialyzed 
with distilled water; the entire content of the dialysis bag was 
submitted to lyophilization and then kept frozen at -8UC. Samples 
of this material were extracted twice with 0.1 M phosphate buffer, 
pH 7.3. The final precipitate was mixtured in the glycine-NaCl- 
buffer, pH 9.6. until dissolution. The resulting solution contained 
the crude plasminogen activators (CPA).
Zym ographic analysis
P repara tive  SD S-PA G E (sodium  dodecyl sulfate 
polyacrylamide gel electrophoresis) was performed according to 
Laemmli11 (1970). The acrylamide gradient gel concentration was 
6-13%. After the procedure (20mA, 4-5hrs), the gel was sliced 
lengthwise and one segment was stained with Coomassie Brilliant 
Blue G. The remaining gel was washed with 50 mM TRIS-HCI 
buffer, pH 7.7, and 0.1 M NaCl containing 2.5% Triton X-100 
and gently rotated for two and a half hours at 458C to remove the 
SDS. To determine the fibrinolytic activity of the protein fractions, 
separated from the gel by preparative electrophoresis, a fibrin- 
agarose Petri dish was used. The position of the plasminogen 
activators in the gel had been established by the zymographic 
technique of Granelli-Pipperno; Reich9 (1978).
Separation of the plasminogen activator with the highest. 
Fibrinolytic activity (PA)
The most fibrinolytic active fraction according to the 
zymographic tests was removed from the washed gel using as a 
guide the stained segment containing standards of known 
molecular weights. Six or seven pieces of this gel with the most 
fibrinolytic active material were submitted to electrophoretic 
elution by the method of Laemmli" (1970). The resulting solution 
contained the most active plasminogen activator (PA).
Fibrinolytic activity
Six ml of a 0.05 M barbital buffer, pH 7.75 containing 1.66 
mM CaCl:, 0.686 mM MgCF and 93.36 mM CaCl plus fibrinogen 
to a final concentration of 1 mg/ml were placed on 8 x 8 cm Petri
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dishes. The fibrinogen was prepared according to Doolittle e ta l.1 
(1967) or Blomback; Blomback* (1957). Fibrin was formed by 
adding 100 ul of 20 Ul/ml thrombin (Topstasine Roche). The 
fibrinolytic active material (30 ^1) was placed in the quadrants of 
the Petri dishes. The results were compared to an International 
Reference Preparation (IRP) of UK from NIBSC.
Preparation of antibodies
White, New Zealand, non-pregnant rabbits weighing 3-4 
kg were subcutaneously injected with 400-500 [ig of the solution 
containing the plasminogen activators, or 250-450 jig of the most 
fibrinolytic active plasm inogen activator according to the 
zymographic tests, or 48 IU of UK-standard, per inoculation. All 
antigens were prepared with Freund’s adjuvant (1:1). After 6 or 7 
inoculations, the rabbits were bled and the antiserum titers were 
assayed by radial im m unodiffusion analysis (Ouchterlony; 
Nilsoon18, 1973).
Purification of the gam m a fraction
Sera from immunized and non-immunized rabbits were 
submitted to chromatography by the method of Miles'7 (1986). 
DEAE-Sephadex A-50 balanced with K ,H P04 buffer, pH 8, was 
used. The resulting eluates were pooled, concentrated and then 
submitted to a second chromatography on Sepharose 4B bound 
to concanavalin A and balanced with NajHPOj buffer, pH 7.4, 
containing 0.4 M CaCl,.
Ainidolytic assays with the chromogenic substrate
Amidolytic assays were carried out with the solution 
containing the plasminogen activator, as well as with the most 
fibrinolytic active plasminogen activator, according to Frieberger* 
(1982). S-2444 (L-pyroglutamyl-glycyl-L-arginine-p-nitroanilide) 
(ORTHO-DIAGNOSTICS), which is UK-specific according to 
Matsuo et al.'* (1983), was used as chromogenic substrate.
Protein determ ination
Protein content was assayed by the microbiuret of Itzhaki; 
Gill10 (1964), Fraction V-Sigma bovine albumin (1 mg/ml) was 
used as standard.
RESULTS
Diluted bovine plasma treated with cellulose sulfate produces 
a fibrinolytic active precipitate. After dialysis, lyophilization and 
extraction, a solution containing plasminogen activators (CPA) is 
obtained. The electrophoresis of CPA can be visualized in Fig. 1 
(A-a2). After electrophoresis, the polyacrylamide gel was purified 
from SDS and then used in the zymographic tests in order to identify 
the protein fractions with fibrinolytic activity (Fig. 1 C-c,). CPA 
was found to contain a number of proteins with different Fibrinolytic 
properties showing molecular weights ranging from 30.000 to 
85.000. The activator with the highest molecular weight in the gel 
(A-a2, B-b,, see arrow) was also the most fibrinolytic active 
component, according to the zymographic tests (C-c,). After elution 
from the polyacrylamide gel, this fraction was submitted to 
electrophoresis. Fig. 1 B-b, shows the electrophoretic profile of this 
plasminogen activator and Fig.l C-c, shows its fibrinolytic activity 
after electrophoretic elution. The gamma fraction of the anti-CPA,
anti-PA, and anti-UK antisera was obtained by chromatography as 
shown in Materials and Methods. Radial immunodiffusion tests 
were carried out to determine the immunological nature of the 
plasminogen activator studied. The precipitation lines that can be 
seen in the agarose gel show that both CPA and PA were 
immunologically recognized using the gamma fraction of the UK- 
standard antiserum (Figs. 2 A and B).
Concomitant, radial immunodiffusion tests were performed 
with the anti-CPA and anti-PA gamma fractions versus t-PA extracted 
from a culture of myeloma cells. In these tests, the antisera had no 
immunological identity with the plasminogen activator used (t-PA).
Immunological nature of the plasminogen activator was 
confirmed by other tests: 1- total inhibition of the fibrinolytic activity 
of the UK-standard when incubated with the anti-CPA gamma 
fraction, with the gamma fraction from the sera of non-immunized 
rabbits used as control; 2- amidolytic activity of the CPA and PA 
solutions against the S-2444 urokinase-specific chromogenic 
substrate, which reacted both with CPA and PA, but not with the t- 
PA standard. These results are presented in Table 1.
The method yielded 200-300 mg CPA/ml bovine plasma, 
corresponding to 1-1.5 mg/ml of fibrinolytic material; the 
fibrinolytic activity of CPA was 0.4 IU/ml and the fibrinolytic 
activity of PA was about 0.6 IU/ml.
/
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SDS-PAGE (Sodium sulfate-polyacrylamide gel electrophoresis) combined 
with fibrinolytic analysis in fibrin-agarose dishes.
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Table 1
Amidolytic activities of bovine plasminogen activators. São Paulo, 1993.
Enzyme
species
Am ido lytic
activ ity
(S-2444)
Specific  
activ ity  
O.D. 405/m in/mg
UK 120 0.011
CPA 185.5 0.017
PA 480 0.044
t-PA - 0.0003
The data are expressed as Ul per mg protein obtained by comparison 
with the International Reference Preparation of Urokinase (see Methods).
DISCUSSION
A brief comparison of some methods of fibrinolytic system 
activation cited in the literature shows that the pioneering 
procedure of Rothschild et al.2' (1975), using cellulose sulfate at 
the concentration of 4 ng/ml, generated a fibrinolytic material on 
the plate. This material was first submitted to fractionated 
prec ip ita tion  w ith 30% am m onium  su lfa te  and then 
chromatographed twice consecutively on Sephadex G-200 for 
further purification. The material was then submitted to SDS- 
polyacrylamide electrophoresis in which, because of its highly- 
aggregating properties, it did not penetrate the space gel, so that 
plate fibrinolytic activity appeared only at the top of the gel, after 
the electrophoretic run.
In the present study, the method was submitted to some 
modifications in order to solve some of the problems cited earlier. 
We used cellulose sulfate at the concentration of 25 ng/ml, and 
the precipitate was solubilized in 0.1 M glycine buffer, pH 9.6, 
containing 5% NaCl. This salt concentration is of vital importance 
for a better yield, since it permits better solubilization of the ma­
terial with fibrinolytic activity. During the subsequent purification 
step, the above material was dialyzed against distilled water, 
becoming insoluble again. Thus, to avoid loss of material, we 
lyophilized the entire content of the dialysis bag. The material 
thus prepared was again solubilized in the presence of salt
whenever it was submitted to electrophoretic separation. With 
these modifications of the preparation of fibrinolytic material, 
we w ere able to obtain CPA fractionation  into different 
plasm inogen activators of different m olecular weights, by 
preparative electrophoresis (Fig. 1-b,).
Miles et al.u' (1981), using human plasma and 50 mg/ml 
dextran sulfate, obtained a preparation with fibrinolytic activity 
equivalent to approximately 9 |xg/ml purified plasmin. In the 
present study, CPA yield was 1-1.5 mg/ml using cellulose sulfate 
and bovine plasma.
In a recent study, Takada et a1.23 (1994) used a heparin like 
polysaccharide, i.e., heparan sulfate at the concentration of 10 j^g/ 
ml, and observed that this procedure was more effective for 
plasminogen activation by t-PA or u-PA than the use of other sulfated 
polysaccharides (dextran sulfate, chondroitin sulfate etc.). In the 
same study, the authors, using u-PA extracted from kidney cell 
cultures after plasmin activation, detected a fibrinolytic material 
with specific activity of about 15x10* IU/mg. In the present study, 
our activator had a specific activity of about 470 IU/mg, i.e., much 
lower than the preparation activated with heparan sulfate. These 
data may suggest the presence of a plasminogen activator inhibitor 
(PAI) in our preparation, a hypothesis that was not tested.
On the basis of the results of the radial immunodiffusion tests 
with isolated monoclonal antibodies and of the amidolytic tests, we 
concluded that the nature of the isolated plasminogen activator is 
similar to that of urokinase. The process of purification and preparation 
of the active fibrinolytic material using cellulose sulfate-activated 
bovine plasma produced a low yield, as commented earlier. However, 
in view of the high costs involved in molecular engineering techniques 
for the production of plasminogen activators on an industrial scale, 
as stated by Dibner; Timmermans6 (1986), we believe that the 
methodology presented here should be considered, since it does not 
involve large expenditures and allows working with a biological 
material that does not involve risks of contamination with AIDS, 
hepatitis or other viruses, besides representing an abundant raw 
material usually discarded.
Studies of PAI by the method of Van Hinsbergh24 (1988) may 
lead to improved yields of the plasminogen activator preparation 
presented here.
RESUMO
Plasma bovino tratado com sulfato de celulose produz, em placas de fibrina, múltiplas formas de ativadores de plasminogênio. A 
fração fibrinoliticamente mais ativa foi isolada por eletroforese preparativa. Testes amidolíticos com substratos cromogênicos e testes 
de imunodifusão radial com anticorpos monoclonais revelaram que o ativador de plasminogênio isolado neste trabalho possui propri­
edades semelhantes às da uroquinase.
UNITERMOS: Bovinos; Plasma; Sulfatos; Ativador de plasminogênio; Anticorpos monoclonais.
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